Benzodiazepine receptor binding in Huntington's disease: [11C]flumazenil uptake measured using positron emission tomography

Gabriella Künig, Klaus L. Leenders, Rosario Sanchez-Pernaute, Angelo Antonini, Peter Vontobel, Aalt Verhagen, Ilonka Günther

Research output: Contribution to journalArticlepeer-review

Abstract

We used positron emission tomography and [11C]flumazenil to analyze the benzodiazepine receptor binding in symptomatic and asymptomatic carriers of the Huntington's disease gene. We found an inverse relationship between [11C]flumazenil and [11C]raclopride binding in the putamen of symptomatic patients, and interpret this result as GABA receptor upregulation.

Original languageEnglish
Pages (from-to)644-648
Number of pages5
JournalAnnals of Neurology
Volume47
Issue number5
DOIs
Publication statusPublished - 2000

ASJC Scopus subject areas

  • Neuroscience(all)

Fingerprint

Dive into the research topics of 'Benzodiazepine receptor binding in Huntington's disease: [11C]flumazenil uptake measured using positron emission tomography'. Together they form a unique fingerprint.

Cite this